Conditions: Arthritis, Rheumatoid
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 123
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether switching to subcutaneous administration of abatacept will be safe in participants with rheumatoid arthritis who previously received long-term therapy with intravenous abatacept

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Abatacept
Intervention descriptions: intervention 1: Subcutaneous injection, 125 mg/mL, once weekly, 48 months

Protocol document: